University of Texas's MD Anderson Research Highlights for Feb. 23
February 24, 2022
February 24, 2022
HOUSTON, Texas, Feb. 24 (TNSJou) -- The University of Texas's MD Anderson Cancer Center issued the following news release:
* * *
Featuring PIK3CA and FGFR targeted therapy advances, new treatments for myelofibrosis, and laboratory discoveries in pancreatic cancer, glioblastoma and CLL
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recently published studies in basic, translational . . .
* * *
Featuring PIK3CA and FGFR targeted therapy advances, new treatments for myelofibrosis, and laboratory discoveries in pancreatic cancer, glioblastoma and CLL
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recently published studies in basic, translational . . .